Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Surg Oncol Clin N Am. 2022 May 31;31(3):321–340. doi: 10.1016/j.soc.2022.03.001

Table 2.

Clinico-pathologic features of novel round cell sarcoma subtypes.

Differential Diagnosis
EWSR1-NFATC2 and FUS-NFATC2 Sarcoma
  • Mostly long bones

  • Children and adults, M>F

  • Round/spindle cells in hyaline background

  • Variable expression of CD99, PAX7, NKX2.2, AE1/AE3

  • Local recurrence and distant metastasis

C/C-Rearranged Sarcoma
  • Trunk and extremities

  • Young adults, M>F

  • Diffuse sheets of undifferentiated round to ovoid cells, intervening fibrous stroma; common necrosis, high mitotic rate

  • Expression of WT1 and ETV4; limited CD99

  • T(4;19)(q35;q13) or t(10;19)(q26;q13) resulting in CIC-DUX4 fusion

  • Very aggressive, poor prognosis

BCOR-Rearranged Sarcoma
  • Bone and soft tissue

  • Children, M>F

  • Primitive small round to ovoid cells solid sheets or nested; variable mitotic rate, rare necrosis

  • Expression of BCOR and/or CCNB3; variable CD99

  • Inv(X)(p11) resulting in BCOR-CCNB3 fusion

  • Aggressive, poor prognosis

EWSR1-PATZ1 Sarcoma
  • Mostly chest wall

  • Wide age range, F=M

  • Small round/spindled cells, fibrous stroma

  • Variable expression of myogenic and neurogenic markers, CD34

  • Local recurrence and distant metastasis